Picture of TELA Bio logo

TELA TELA Bio Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-10.88%
3m-31.79%
6m-32.26%
1yr-64.46%
Volume Change (%)
10d/3m+24.6%
Price vs... (%)
52w High-56.31%
50d MA-19.86%
200d MA-31.33%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-72.16%
Return on Equity-281.23%
Operating Margin-75.4%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of TELA Bio EPS forecast chart

Profile Summary

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 17th, 2012
Public Since
November 8th, 2019
No. of Shareholders
64
No. of Employees
227
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
24,649,595

TELA Share Price Performance

Upcoming Events for TELA

Q1 2024 TELA Bio Inc Earnings Release

TELA Bio Inc Annual Shareholders Meeting

Q2 2024 TELA Bio Inc Earnings Release

Similar to TELA

Picture of 908 Devices. logo

908 Devices.

us flag iconNASDAQ Global Market

Picture of Alpha Teknova logo

Alpha Teknova

us flag iconNASDAQ Global Market

Picture of AtriCure logo

AtriCure

us flag iconNASDAQ Global Market

Picture of Brainsway logo

Brainsway

us flag iconNASDAQ Global Market

Picture of Castle Biosciences logo

Castle Biosciences

us flag iconNASDAQ Global Market

FAQ